Bio-Connect

InVivoMAb recombinant Flt-3L-Ig (hum/hum)

BE0098
Bio X Cell
Product group Proteins / Signaling Molecules
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb recombinant Flt-3L-Ig (hum/hum)
  • Delivery Days Customer
    7
  • Certification
    Research Use Only
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352202

References

  • Borowski S, Tirado-Gonzalez I, Freitag N, et al. Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics. Front Immunol. 2020,11:1316. doi: 10.3389/fimmu.2020.01316
    Read this paper
  • Schrand B, Clark E, Levay A, et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun. 2018,9(1):3348. doi: 10.1038/s41467-018-05566-x
    Read this paper
  • Blois SM, Freitag N, Tirado-González I, et al. NK cell-derived IL-10 is critical for DC-NK cell dialogue at the maternal-fetal interface. Sci Rep. 2017,7(1):2189. doi: 10.1038/s41598-017-02333-8
    Read this paper
  • Liao G, O'Keeffe MS, Wang G, et al. Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4(+) T Cells. Front Immunol. 2014,5:35. doi: 10.3389/fimmu.2014.00035
    Read this paper
  • Hennion-Tscheltzoff O, Leboeuf D, Gauthier SD, et al. TCR triggering modulates the responsiveness and homeostatic proliferation of CD4+ thymic emigrants to IL-7 therapy. Blood. 2013,121(23):4684-93. doi: 10.1182/blood-2012-09-458174
    Read this paper
  • Tirado-González I, Barrientos G, Freitag N, et al. Uterine NK cells are critical in shaping DC immunogenic functions compatible with pregnancy progression. PLoS One. 2012,7(10):e46755. doi: 10.1371/journal.pone.0046755
    Read this paper
  • Guikema JE, Gerstein RM, Linehan EK, et al. Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge. J Immunol. 2011,186(4):1943-50. doi: 10.4049/jimmunol.1002422
    Read this paper